Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada T6G 2E1.
Biomed Res Int. 2013;2013:258095. doi: 10.1155/2013/258095. Epub 2012 Dec 20.
We previously demonstrated that Peganum harmala L. extract and its main active constituents, harmine and harmaline inhibit the 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-mediated induction of the carcinogen-activating enzyme, Cyp1a1, in vitro. However, the effect of both alkaloids on Cyp1a1 in vivo has not been investigated. Therefore, the aim of this study is to examine the effect of harmine and harmaline on TCDD-mediated induction of Cyp1a1 in mice livers and lungs. C57BL/6 male mice were distributed into four groups (n = 6). First group received vehicle, while the second group received TCDD (i.p.). The third and fourth groups received either harmine or harmaline (i.p.) × 3 times along with TCDD one time with the mid dose of harmine and harmaline. All mice were sacrificed after 14 h from TCDD injection, and livers and lungs were isolated. The effect of harmine and harmaline on TCDD-mediated induction of Cyp1a1 mRNA, protein, and activity levels was determined using real-time PCR, Western blot analysis, and 7-ethoxyresurofin as a substrate, respectively. Our results showed that harmine and harmaline significantly decreased the TCDD-mediated induction of Cyp1a1 in both the livers and lungs. We concluded that harmine and harmaline are promising candidate to inhibit TCDD-mediated induction of Cyp1a1 in mice hepatic and extrahepatic tissues.
我们之前的研究表明,骆驼蓬提取物及其主要活性成分,哈尔明和哈尔满,能够抑制 2,3,7,8-四氯二苯并对二恶英(TCDD)诱导的致癌酶 Cyp1a1 的体外表达。然而,这两种生物碱对 Cyp1a1 的体内作用尚未得到研究。因此,本研究旨在探究哈尔明和哈尔满对 TCDD 诱导的 Cyp1a1 在小鼠肝脏和肺部中的表达的影响。将 C57BL/6 雄性小鼠分为四组(每组 6 只)。第一组给予载体,第二组给予 TCDD(腹腔注射)。第三组和第四组分别给予哈尔明和哈尔满(腹腔注射)×3 次,同时给予 TCDD 1 次,哈尔明和哈尔满的剂量为中等剂量。所有小鼠在 TCDD 注射后 14 小时处死,分离肝脏和肺部。采用实时 PCR、Western blot 分析和以 7-乙氧基香豆素为底物分别测定哈尔明和哈尔满对 TCDD 诱导 Cyp1a1 mRNA、蛋白和活性水平的影响。结果表明,哈尔明和哈尔满能显著降低 TCDD 诱导的 Cyp1a1 在肝脏和肺部中的表达。我们得出结论,哈尔明和哈尔满是抑制 TCDD 诱导 Cyp1a1 在小鼠肝外组织中表达的有前途的候选物。